Clinical Research Directory
Browse clinical research sites, groups, and studies.
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
Sponsor: Jonsson Comprehensive Cancer Center
Summary
This clinical trial constructs and tests a novel multinuclear metabolic magnetic resonance imaging (MRI) sequence in patients with glioma (brain tumor) that is newly diagnosed or has come back (recurrent). This trial aims to develop new diagnostic imaging technology that may bridge gaps between early detection and diagnosis, prognosis, and treatment in brain cancer.
Official title: Simultaneous Multinuclear (Na+/H+) Metabolic MRI in Brain Tumors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2021-09-01
Completion Date
2027-09-10
Last Updated
2025-11-14
Healthy Volunteers
Yes
Interventions
Biospecimen Collection
Undergo collection of tissue samples
Diagnostic Imaging
Undergo multinuclear metabolic imaging
Magnetic Resonance Imaging
Undergo MRI
Locations (1)
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States